Concepedia

Simeng Xu

SX

Statistics

Publications

8

Citations

261

H-Index

8

Active since

2018

Affiliations

Hunan Normal University(Current)

Xiangya Hospital Central South University

Central South University

Yueyang Hospital

Shanghai University of Traditional Chinese Medicine

Simeng Xu is an author at Hunan Normal University specializing in pharmacology, medicine, and tumor biology.

ORCID

Top concepts

Publications per year

2018–2022

8

Publications

8

Down‐regulation of PKM2 decreases FASN expression in bladder cancer cells through AKT/mTOR/SREBP‐1c axis

Ting Tao, Qiongli Su, Simeng Xu et al. · Journal of Cellular Physiology · 2018 · 87 citations

, , +21

Reduction-sensitive platinum (IV)-prodrug nano-sensitizer with an ultra-high drug loading for efficient chemo-radiotherapy of Pt-resistant cervical cancer in vivo

Kejun Luo, Wenxuan Guo, Yanting Yu et al. · Journal of Controlled Release · 2020 · 48 citations

, , +10

Inhibition of PKM2 Enhances Sensitivity of Olaparib to Ovarian Cancer Cells and Induces DNA Damage

Sichun Zhou, Duo Li, Di Xiao et al. · International Journal of Biological Sciences · 2022 · 41 citations · Full text

, , +17

Vitamin A prevents lipopolysaccharide‐induced injury on tight junctions in mice

Caimei He, Xin Hu, Di Xiao et al. · Food Science & Nutrition · 2020 · 23 citations · Full text

4-Methoxydalbergione Inhibits Bladder Cancer Cell Growth via Inducing Autophagy and Inhibiting Akt/ERK Signaling Pathway

Haifang Du, Ting Tao, Simeng Xu et al. · Frontiers in Molecular Biosciences · 2022 · 18 citations · Full text

1–5 of 8